← Eichor
Study identifier: NCT05331911 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors

Condition: Hepatocellular Carcinoma  ·  Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital

PhasePhase 4
Planned participants500
Who can joinAll sexes, 20 Years to 80 Years
Healthy volunteersNo

About this study

This is a two-arm, parallel-group randomized clinical trial. Routine perioperative care would be performed in volunteers with primary Hepatocellular carcinoma. The study will enroll approximately 500 volunteers to compare the progression-free or overall survival in patients undergoing elective partial hepatectomy for primary liver tumors between propofol and sevoflurane for the maintenance of anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

Guan-Yu Chen, M.D.  ·  07-3121101  ·  kindtaco@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Kaohsiung Medical University Chung-Ho Memorial HospitalKaohsiung City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05331911